tiprankstipranks
Cogent Biosciences, Inc. (COGT)
NASDAQ:COGT
US Market
COGT
Cogent Biosciences
RESEARCH TOOLSreports
Want to see COGT full AI Analyst Report?

Cogent Biosciences (COGT) Income Statement

717 Followers

Cogent Biosciences Income Statement

Last quarter (Q1 2026), Cogent Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Cogent Biosciences's net income was $-97.35M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.62M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 328.74M$ 275.94M$ 208.13M$ 147.84M$ 75.55M
Depreciation and Amortization
$ 4.62M$ 4.35M$ 3.59M$ 5.88M$ 1.99M
EBITDA
$ -328.74M$ -271.59M$ -204.54M$ -141.96M$ -73.56M
Operating Income
$ -333.36M$ -275.94M$ -208.13M$ -147.84M$ -75.55M
Other Income/Expenses
$ 4.43M$ 20.08M$ 15.72M$ 7.60M$ 3.28M
Pretax Income
$ -328.94M$ -255.86M$ -192.41M$ -140.24M$ -72.27M
Net Income
$ -328.94M$ -255.86M$ -192.41M$ -140.24M$ -72.27M
Per Share Metrics
Basic EPS
$ -2.55$ -2.46$ -2.42$ -2.26$ -1.85
Diluted EPS
$ -2.55$ -2.46$ -2.42$ -2.26$ -1.85
Weighted Average Shares Outstanding
 67.60M 103.86M 79.66M 58.74M 38.73M
Weighted Average Shares Outstanding (Diluted)
 67.60M 103.86M 79.66M 58.74M 38.73M
Currency in USD

Cogent Biosciences Earnings and Revenue History